Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 7	$ 25
Accounts receivable - trade (less allowance for doubtful accounts)	525	494
Unbilled revenue	346	319
Inventories	762	733
Current regulatory assets	366	365
Other current assets	162	139
Total current assets	2,264	2,181
Property, Plant, and Equipment, Net	36,304	33,776
Investments and Other Assets:
Nuclear decommissioning trust fund	1,342	1,150
Goodwill	411	411
Regulatory Asset, Noncurrent	2,397	1,810
Pension and other postretirement benefits	757	581
Other assets	1,123	921
Total investments and other assets	6,030	4,873
TOTAL ASSETS	44,598	40,830
Current Liabilities:
Long-Term Debt, Current Maturities	317	849
Short-term debt	1,143	536
Accounts and wages payable	1,059	1,136
Interest accrued	196	147
Customer deposits	223	176
Other current liabilities	475	501
Total current liabilities	3,413	3,345
Long-Term Debt, Excluding Current Maturities	17,262	15,121
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and production and investment tax credits, net	4,474	4,176
Regulatory liabilities	5,897	5,512
Asset retirement obligations	822	772
Other deferred credits and liabilities	487	426
Total deferred credits and other liabilities	11,680	10,886
Commitments and Contingencies (Notes 2, 9, and 14)
Shareholders' Equity:
Common stock	3	3
Other paid-in capital, principally premium on common stock	7,513	7,216
Retained earnings	4,604	4,136
Accumulated other comprehensive loss	(6)	(6)
Total shareholders' equity	12,114	11,349
Noncontrolling Interests	129	129
Total equity	12,243	11,478
TOTAL LIABILITIES AND EQUITY	$ 44,598	$ 40,830